Urology Doctors in Lake Success, NY Accepting Medicare

5 Urology doctors found. Showing 1 - 5

Michael M Ziegelbaum, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2001 Marcus Ave, Suite N-214, Lake Success, NY 11042 Phone: 516-437-4228    Fax: 516-355-0637

David M Hoenig, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 450 Lakeville Road, Suite M41, Smith Institute For Urology, Lake Success, NY 11042 Phone: 516-734-8597    Fax: 516-734-8538

Sanford A Meyersfield, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2001 Marcus Ave, Suite N-214, Lake Success, NY 11042 Phone: 516-437-4228    Fax: 516-355-0637

Michael A Levine, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2001 Marcus Ave, Suite N-214, Lake Success, NY 11042 Phone: 516-437-4228    Fax: 516-355-0637

Mitchell I Buchbinder, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2001 Marcus Ave, Suite N-214, Lake Success, NY 11042 Phone: 516-437-4228    Fax: 516-355-0637

News Archive

ECTS, IOF publish guidance document to manage GIO

Oral glucocorticoids are commonly prescribed for a wide variety of disorders, most commonly for rheumatoid arthritis, obstructive pulmonary disease and inflammatory bowel diseases. However, the use of these medications can result in rapid bone loss during the first three to six months of therapy, leading to increased risk of fragility fractures.

PanOptica completes $30 million Series A financing

PanOptica, Inc., a private biopharmaceutical company focused on licensing and developing innovative ophthalmology therapies, today announced that it has raised $30 million in a Series A financing. This round was led by SV Life Sciences and Third Rock Ventures.

Ergonomic and physiotherapeutic interventions for treating work-related complaints of the arm, neck or shoulder in adults

Many conservative methods used to treat work-related complaints of the upper body have only limited effectiveness, according to an updated systematic review by Arianne Verhagen, Ph.D., and her colleagues in the Netherlands.

Good quality care for young people with type-1 diabetes unevenly distributed in Ireland

New research launched today to coincide with World Diabetes Day which takes place tomorrow, 14th November 2013 revealed that good quality care for young people with type-1 diabetes is unevenly distributed throughout Ireland.

Onyx Pharmaceuticals commences Phase 1 study of ONX 0912 oral proteasome inhibitor for cancer

Onyx Pharmaceuticals, Inc. today announced the initiation of a Phase 1 study of ONX 0912, an oral proteasome inhibitor, in patients with advanced refractory or recurrent solid tumors.

Read more Medical News

› Verified 5 days ago